Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

7 Semiconductor Stocks to Sell Now

For the current week, the overall ratings of seven Semiconductor stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Biotechnology Stocks to Sell Now

This week, the ratings of seven Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Use Any JCP Jumps to Sell JCPenney Stock NOW

Don't be fooled by Tuesday's brief bout of optimism in JCP stock. JCPenney still faces a huge uphill climb to regain its losses, customers and dignity.

Should I Buy GlaxoSmithKline (GSK)? 3 Pros, 3 Cons

GlaxoSmithKline is seeking approval for the world's first malaria vaccine, but high debt and low growth mean investors should think twice before buying.

5 Worst Blue Chips to Own Before Earnings

A close look at the Dow reveals five ugly blue chips that still are holding back the index -- and that investors should avoid if they want to profit in 2014.

5 Worst Sectors to Avoid This Week

This week, the Computer and Personal Electronics, Energy Services, Computer and Personal Electronics, Oil and Gas, and Marine sectors look weak according to Portfolio Grader.

5 Stocks With Ugly Earnings Growth — KWK GNK SOL CRK LM

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Poor Cash Flow — KWK STP ATPG EDN AONE

This week, these five stocks have the worst ratings in Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

4 Capital Markets Stocks to Sell Now

The overall ratings of four Capital Markets stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Bad Operating Margin Growth — SYUT CTEL HKTV IMMU FMBI

This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Awful Sales Growth — NAVB CTEL HKTV CUR IMMU

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

3 Medical Devices Stocks to Sell Now

This week, the ratings of three Medical Devices stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Media Stocks to Sell Now

The ratings of three Media stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Stocks You Need to Sell NOW

Recommendations to sell are so rare on Wall Street that when analysts actually dole one out, you have to take notice. Here are three such stocks to sell.

BP Stock Still a ‘Sell’ as Legal Quagmire Continues

While BP stock holders have been afforded a small sign of legal relief, the potential for monster fines in another piece of the case still looms.

17 Oil and Gas Stocks to Sell Now

The overall ratings of 17 Oil and Gas stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Internet and Web Service Stocks to Sell Now

This week, the overall grades of five Internet and Web Service stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Pharmaceutical Stocks to Sell Now

The ratings of three Pharmaceutical stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Chemicals Stocks to Sell Now

This week, the overall grades of four Chemicals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").